In glioma patients with different WHO grades, TGF-β1 and TGF-β2 were found to be the major TGF-β isoforms secreted by glioma cells which are able to downregulate cellular adhesion molecule (CAM) expression on GBM endothelial cells to prevent T cell infiltration (131). Here, TGFB1 is linked to central nervous system cancer.